EDAP TMS S.A. (ADR)
General ticker "EDAP" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $77.0M (TTM average)
EDAP TMS S.A. (ADR) follows the US Stock Market performance with the rate: 13.6%.
Estimated limits based on current volatility of 2.7%: low 2.29$, high 2.41$
Factors to consider:
- Total employees count: 149 as of 2003
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [1.62$, 4.19$]
- 2025-12-31 to 2026-12-31 estimated range: [1.81$, 4.39$]
Financial Metrics affecting the EDAP estimates:
- Positive: with PPE of -4.0 at the end of fiscal year the price was low
- Negative: negative Operating income
- Positive: 41.86 < Shareholder equity ratio, % of 47.52 <= 63.39
- Negative: Operating cash flow per share per price, % of -17.38 <= 0.33
- Positive: -14.38 < Investing cash flow per share per price, % of -5.27
- Positive: Interest expense per share per price, % of 0.30 <= 0.79
- Positive: Inventory ratio change, % of -4.31 <= -0.75
- Positive: Industry inventory ratio change (median), % of -1.44 <= -0.15
Short-term EDAP quotes
Long-term EDAP plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | €55.11MM | €60.42MM | €64.11MM |
| Operating Expenses | €59.37MM | €80.24MM | €84.65MM |
| Operating Income | €-4.26MM | €-19.81MM | €-20.53MM |
| Non-Operating Income | €2.16MM | €-0.72MM | €1.80MM |
| Interest Expense | €0.17MM | €0.23MM | €0.24MM |
| R&D Expense | €4.92MM | €6.96MM | €7.73MM |
| Income(Loss) | €-2.10MM | €-20.53MM | €-18.73MM |
| Taxes | €0.84MM | €0.64MM | €0.29MM |
| Profit(Loss)* | €-2.93MM | €-21.18MM | €-19.02MM |
| Stockholders Equity | €71.63MM | €56.92MM | €40.90MM |
| Inventory | €11.78MM | €15.11MM | €18.50MM |
| Assets | €101.12MM | €91.55MM | €86.06MM |
| Operating Cash Flow | €-3.02MM | €-14.68MM | €-13.58MM |
| Capital expenditure | €2.18MM | €4.30MM | €4.10MM |
| Investing Cash Flow | €-2.38MM | €-4.34MM | €-4.12MM |
| Financing Cash Flow | €21.74MM | €-0.91MM | €4.63MM |
| Earnings Per Share** | €-0.09 | €-0.57 | €-0.51 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.